Nav: Home

ESMO Summit Africa 2017

February 01, 2017

The ESMO Summit Africa is a three-day educational event with presentations focused on several key disease sites. Created for oncology professionals in Africa by international and local key opinion leaders, the summit will put into context the most significant treatment advances presented at the ESMO annual congress.

The summit objectives are to provide the oncology community with a summary of the most significant treatment advances presented at the ESMO Congresses; to review the current standard of care for key malignancies from a local and international perspective and to discuss the current controversies in the management of specific cancers.

The meeting targets medical and clinical oncologists, pharmacists, nurses, students, fellows, residents, general practitioners in oncology and other oncology healthcare professionals.

Check out the Scientific Programme here: http://www.esmoafrica2017.co.za/programme/
-end-


European Society for Medical Oncology

Related Oncology Articles:

Hippocampal avoidance during WBRT reduces risks on NRG Oncology trial
Results from the NRG Oncology clinical study NRG-CC001 concluded that lowering radiotherapy dose to hippocampal stem cells improves cognitive and patient-reported outcomes for patients with brain metastases.
Dozens of non-oncology drugs can kill cancer cells
Researchers tested approximately 4,518 drug compounds on 578 human cancer cell lines and found nearly 50 that have previously unrecognized anti-cancer activity.
10-year results of NRG Oncology/NSABP B-42 trial
In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer.
Scientists discover reasons why targeted immuno-oncology drugs sometimes fail
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G.
NRG oncology trial of metformin for non-small cell lung cancer
Initial results of NRG-LU001 indicate that, although the diabetes agent metformin was well-tolerated by patients, the agent has not clearly improved progression-free survival (PFS) or overall survival (OS) for trial participants with locally advanced non-small cell lung cancer (NSCLC).
Precision oncology insights revealed for colorectal cancer
Findings published in the Journal of Clinical Oncology could help define strategies to more effectively treat colorectal cancer, the second leading cause of cancer death in the United States.
Precision oncology in advanced cancer patients improves overall survival
Resource use intensity for patients in the targeted group was lower in both higher-cost, acute settings such as inpatient and ER as well in the lower acuity outpatient setting, compared to control patients.
New algorithm decodes spine oncology treatment
Experts explain their approach to treating patients who are living longer with cancer that has spread to the spine, as the options for metastatic spine tumors increase.
Hereditary cancer syndromes focus of JAMA Oncology collection
JAMA Oncology published a collection of articles on hereditary cancer syndromes, including Li-Fraumeni and Lynch syndromes.
Scientific advances in thoracic oncology in 2016 highlighted by the IASLC
Capturing and summarizing the remarkable progress in lung cancer prevention, diagnosis, staging and treatment in 2016, the International Association for the Study of Lung Cancer (IASLC) announces the second annual publication of 'Scientific Advances in Thoracic Oncology,' available online now and in the August 2017 issue of the IASLC's Journal of Thoracic Oncology (JTO).
More Oncology News and Oncology Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.